Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
This study has been terminated.
(Study was terminated due to cardiac toxicities)
Sponsor:
Symphony Evolution, Inc.
Information provided by:
Symphony Evolution, Inc.
ClinicalTrials.gov Identifier:
NCT00322673
First received: May 4, 2006
Last updated: February 18, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | May 2007 |
| Primary Completion Date: | November 2006 (Final data collection date for primary outcome measure) |